The 2018 Global Wearable Injectors Market by Type, Technology, Application, End-user, Size and Forecast (2012-2024): Expected to Register a CAGR of 24.53% - ResearchAndMarkets.com

November 26, 2018

DUBLIN--(BUSINESS WIRE)--Nov 26, 2018--The “Global Wearable Injectors Market by Type, by Technology, by Application, by End-user, by Size and Forecast, 2012-2024” report has been added to ResearchAndMarkets.com’s offering.

Global Wearable Injectors market report provides analysis for the period 2012-2024. The market study reveals that the Global Wearable Injectors market is projected to rise over a CAGR of 24.53% during 2018-2024 in terms of value.This growth is driven by rising usage of advance drug delivery devices at home. Rise in prevalence of chronic diseases among old age population is surging the demand for wearable injector’s products over the projected time frame.

On the basis of the type of product, body-worn patch injector devices hold 46.92% market share of global wearable injectors market. Off-Body Worn Belt Injector and Bolus Injector type devices will grow with a CAGR of 5.78% and 42.36% in term of value, respectively. North America is leading the global wearable injectors market with a CAGR of 24.48%, in terms of value. Electronic injectors is likely to surpass USD 7,861.5 million by 2024 owing shift in usage of self-administrative injectable devices and availability at economic prices.

Major Findings

The demand for Global Wearable Injectors market is expected to grow at a significant rate, during forecast period. Wearable Injectors is witnessing tremendous growth owing to increasing life expectancy and fall in birth rates increasing old age population. The elderly population requires extensive care, as they are prone to illness due to low immunity levels and high recovery time. The elderly people are more susceptible to chronic diseases, such as cancer, diabetes, neurological disorders and cardiovascular diseases, thus increasing the usage of wearable injectors across the globe.Body-worn patch injectors are the largest contributor, in terms of value, as compared to Off-body worn belt injectors. It is expected to rise with CAGR over 5.8% by value during the forecast period, 2012-2024.Global Wearable Injectors market for technology segment is estimated to rise with a CAGR over 20.69% during the period of 2018-2024 with electronic injectors being the highest revenue generator, with market share of 54.76%.North America is the fastest growing region in the Wearable Injectors market and is expected to propel with a CAGR over 24.48% by value during the forecast period, 2018-2024 with Japan being the fastest growing market having a CAGR over 21.9% and expected to reach revenue of around USD 1,170.4 million by the end of 2024.Market Dynamics Factors Driving Market Growth Global Ageing PopulationAccelerating Pervasiveness of Chronic DiseasesGrowing Demand for Advance Drug DeliveryRise in Pipeline for Biologic DrugsMarket Analysis of Drivers Over Forecast Period Factors Hindering Market Growth Alternative Drug Delivery MethodsDisadvantage of Wearable InjectorChallenges Analysis On Market Forecast Market Opportunities High Usage of Wearable Injectors in Emerging MarketsKey Stakeholders ProfiledBecton, Dickinson and CompanyMedtronicJohnson & JohnsonF. Hoffmann-La RocheOther ProfilesUnilife CorporationCeQur SASensile Medical AGEnable InjectionsScPharmaceuticals, Inc.SteadyMed Ltd.Insulet CorporationYpsomed GroupWest Pharmaceutical Services, Inc.Buhler Motor GmbHCan S.p.A.

Topics Covered

1. Research Methodology

2. Executive Summary

3. Market Outlook

4. Global Wearable Injectors Market Size and Forecast (2012 - 2024)

5. Global Wearable Injectors Market, by Type

6. Global Wearable Injectors Market, by Technology

7. Global Wearable Injectors Market, by Application

8. Global Wearable Injectors Market, by End User

9. Global Wearable Injectors Market, by Geography

10. Competitive Landscape

For more information about this report visit https://www.researchandmarkets.com/research/dfhfxp/the_2018_global?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181126005374/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Infusions and Injectables,Wearable Technology,Needles and Syringes



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 11/26/2018 07:24 AM/DISC: 11/26/2018 07:24 AM


Update hourly